Vera Therapeutics VERA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$368.95M-23.1% | -$299.62M-18.9% | -$251.94M-15.4% | -$218.28M-24.4% | -$175.46M-15.3% | ||
| $523K+11.8% | $468K+20.6% | $388K+37.1% | $283K+58.1% | $179K+70.5% | ||
| $43.39M+14.4% | $37.93M+14.3% | $33.18M+14.3% | $29.02M+18.8% | $24.42M+17.4% | ||
| -$293.2M-21.6% | -$241.1M-14.7% | -$210.29M-13.5% | -$185.27M-19.3% | -$155.26M-15.3% | ||
| $466K-26.0% | $630K-46.3% | $1.17M-8.2% | $1.28M+10.3% | $1.16M+19.2% | ||
| $41.15M-78.8% | $194.29M+280% | -$107.76M+39.3% | -$177.52M+22.4% | -$228.74M+50.6% | ||
| —— | —— | —— | —— | —— | ||
| $311.31M+0.8% | $308.9M-11.4% | $348.57M0.0% | $348.51M+5.1% | $331.67M-45.3% | ||
| $59.26M-77.4% | $262.08M+759% | $30.52M+27.0% | $24.04M+272% | -$14.02M-130% | ||
| -$293.66M-21.5% | -$241.73M-14.3% | -$211.47M-13.4% | -$186.55M-19.3% | -$156.41M-15.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Vera Therapeutics's cash flow data come from?
- Every line is extracted from Vera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.